Valsartan and Hydrochlorothiazide 160/25 mg – Novartis
Effective management of hypertension is critical for maintaining long-term cardiovascular health. This combination medication is formulated for patients requiring precise blood pressure control, helping to reduce the risks associated with hypertension such as stroke and heart-related complications. By targeting multiple pathways in the body, this treatment offers a reliable solution for managing blood pressure levels effectively.
Specifications
| Active Substance | Hydrochlorothiazide, Valsartan |
| Form | 28 pills |
| Dosage | 160/25 mg |
| Manufacturer | Novartis |
Description and Use Case
This medication utilizes a dual-action mechanism to manage hypertension. It combines Valsartan, an Angiotensin II receptor antagonist (ARB), with Hydrochlorothiazide, a diuretic. The Valsartan component works by relaxing blood vessels, while the Hydrochlorothiazide assists in reducing fluid retention in the body.
This synergistic approach is designed to provide more effective blood pressure reduction than either component used alone. It is ideal for patients whose hypertension is not adequately controlled by a single-ingredient medication. This pharmaceutical-grade formulation from Novartis ensures-consistent quality and adherence to high manufacturing standards, making it a trusted choice for cardiovascular maintenance.